Guided Therapeutics (GTHP) Current Deferred Tax Assets (2012 - 2016)

Guided Therapeutics (GTHP) has 5 years of Current Deferred Tax Assets data on file, last reported at $795000.0 in Q4 2016.

• For the quarter ending Q4 2016, Current Deferred Tax Assets rose 27.0% year-over-year to $795000.0; the trailing twelve-month figure through Dec 2016 stood at $795000.0 (up 27.0% YoY), and the FY2016 full-year result was $795000.0, up 27.0% from the prior year.
• Current Deferred Tax Assets grew to $795000.0 in Q4 2016, from $626000.0 in the prior quarter.
• In the past five years, Current Deferred Tax Assets ranged from a high of $795000.0 in Q4 2016 to a low of $277000.0 in Q4 2012.
• A 5-year average of $490200.0 and a median of $466000.0 in 2014 frame the typical range for Current Deferred Tax Assets.
• Across the five-year window, Current Deferred Tax Assets climbed 3.61% in 2013 and jumped 62.37% in 2014, its largest moves.
• Tracing GTHP's Current Deferred Tax Assets over 5 years: stood at $277000.0 in 2012, then gained by 3.61% to $287000.0 in 2013, then jumped by 62.37% to $466000.0 in 2014, then surged by 34.33% to $626000.0 in 2015, then increased by 27.0% to $795000.0 in 2016.
• Business Quant data shows GTHP's Current Deferred Tax Assets at $795000.0 in Q4 2016, $626000.0 in Q4 2015, and $466000.0 in Q4 2014.